High-Quality and Intensive Post-cardiac Arrest Care Leads to Positive Outcomes: An Interesting Case Report
Maimouna Dhou Nourein1, Weaam Ibraheem2,3, Abdalla Diyab1
1Rehabilitation Medicine, Salma Rehabilitation Hospital, Abu Dhabi, ARE.
Cureus
|October 30, 2025
Summary
A prolonged out-of-hospital cardiac arrest (OHCA) with poor initial prognosis showed significant recovery. Early holistic rehabilitation is crucial for improving quality of life after OHCA.
Area of Science:
- Emergency Medicine
- Neurology
- Rehabilitation Medicine
Background:
- Out-of-hospital cardiac arrest (OHCA) has a low survival rate, around 10%.
- Research focuses on prevention, prompt response, and outcome improvement for OHCA.
- Initial objective tests, like EEG, can predict poor outcomes after cardiac arrest.
Related Concept Videos
Cardiopulmonary Resuscitation I: Adult
565
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
565
Cardiopulmonary Resuscitation IV: Pharmacological Management
635
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
635
Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
Cardiopulmonary Resuscitation III: AED Use
512
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
512
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455


